At least CSL won’t lose any money because we are govt backed but the share price could take a hit from recent buyers bailing out.
- Forums
- ASX - By Stock
- CSL
- AstraZeneca defends dosing error in trial
AstraZeneca defends dosing error in trial, page-2
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$300.77 |
Change
5.990(2.03%) |
Mkt cap ! $145.3B |
Open | High | Low | Value | Volume |
$295.29 | $302.30 | $295.20 | $232.9M | 775.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $300.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$300.82 | 2599 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 375 | 315.800 |
2 | 605 | 313.060 |
2 | 8 | 305.000 |
1 | 10 | 304.000 |
1 | 16 | 303.950 |
Price($) | Vol. | No. |
---|---|---|
242.120 | 328 | 2 |
285.000 | 1039 | 28 |
285.740 | 3103 | 5 |
285.960 | 20 | 2 |
290.000 | 3 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online